Stone started to received puberty blockers at 10 and took them for around five years before taking Estrogen.
Stone is male. You seem to be very focused on males and making sure they are centred in your feminism. But, you will find the overwhelming number of posters on this board will centre females in their activism.
For good reason.
The health risks for females is much higher than for males to transition. Firstly, there are risks associated with puberty blockers. Or, freespirit have you missed the backtracking that has been happening for major health organisations around the world. They are saying clearly that puberty blockers are NOT reversible and can be very harmful.
www.ncbi.nlm.nih.gov/pmc/articles/PMC6709704/#S5title
This 2019 study showed that female transitioners who took PBs did not ever recover their bone density as they discuss in the section on puberty blockers.
However, Z-scores in the trans boys also showed an expected drop during GnRHa treatment. Similarly, they did not fully Bmake up their bone loss as Z-scores at age 22 were still lower than baseline (aBMD Z-score − 0.33 ± 1.12 and BMAD Z-score average − 0.033 ± 0.95), despitea small increase in absolute aBMD. One transman at age 22 had a Z-score of < −2.0.
There was a series done in Sweden that followed the life of transitioners. One was Leo. A female who suffered significant skeletal damage due to use of puberty blockers.
www.svtplay.se/video/33358590/uppdrag-granskning/mission-investigate-trans-children-avsnitt-1?id=jp9dBRA
Here is some information about the documentaries in case you don't want to watch.
Trusting the advice of the health service, Leo’s parents agreed to start her on puberty blockers at 11 years old. After a period of euphoria following the beginning of the treatment, Leo’s mental health deteriorated, and she became suicidal. In spite of sharing their growing doubts, anxiety, and distress with the healthcare providers, Leo’s parents were continually told that things would get better. Leo and her parents were instead praised and reinforced for being “brave.”
The exposé follows Leo’s heartbreaking degradation. Her back begins to hurt constantly, but there is no follow-up from the health service, and treatment with puberty blockers continues. Finally, tests and images confirm the worst fears.
Sweden’s head of pediatric endocrinology (who had no involvement in Leo’s treatment) reviewed her test results and concluded that she had spinal fractures and two malformed vertebrae – highly likely as a result of the puberty blockers that were nonetheless continued for three more months after the damage was diagnosed.
Puberty blockers stop the body’s growth and bone mineralization, but these risks were never adequately described to the parents. Leo’s mother calls it “a healthy skeleton that was destroyed” by experimental medicine. (For more information on puberty blockers and their side effects, please refer to Stats for Gender, Sweden’s evidence review, and the UK National Institute for Health and Care Excellence (NICE) systematic evidence review.)
From: genspect.org/swedish-documentary-stopping-the-trans-train/
Then there is this from the FDA July 1, 2022:
publications.aap.org/aapnews/news/20636/Risk-of-pseudotumor-cerebri-added-to-labeling-for?autologincheck=redirected
The link requires a log in but the FDA identified six cases that supported a plausible association between GnRH agonist use and pseudotumor cerebri. All subjects were females aged between 5 and 12 years. Five were undergoing treatment for central precocious puberty and one for ‘transgender care’. The onset of pseudotumor cerebri symptoms ranged from just three to 240 days after the start of their GnRH agonist treatment.
So, wonderful to hear that you are so up to date with Stone's transition. However, you seem to be missing something. And that is the bulk of the current transitioning youth cohort is female. Not male. And females have a much greater degree of risk to the drugs used for transitioning.
If you are at all interested, just Google Lupron and class action lawsuit.
www.pbs.org/newshour/health/women-fear-drug-they-used-to-halt-puberty-led-to-health-problems
For years, Sharissa Derricott, 30, had no idea why her body seemed to be failing. At 21, a surgeon replaced her deteriorated jaw joint. She’s been diagnosed with degenerative disc disease and fibromyalgia, a chronic pain condition. Her teeth are shedding enamel and cracking.
and
More than 10,000 adverse event reports filed with the FDA reflect the experiences of women who’ve taken Lupron. The reports describe everything from brittle bones to faulty joints.
and
Women who used Lupron a decade or more ago to delay puberty or grow taller described the short-term side effects listed on the pediatric label: pain at the injection site, mood swings and headaches. Yet they also described conditions that usually affect people much later in life. A 20-year-old from South Carolina was diagnosed with osteopenia, a thinning of the bones, while a 25 year-old from Pennsylvania has osteoporosis and a cracked spine. A 26 year-old in Massachusetts needed a total hip replacement. A 25-year-old in Wisconsin, like Derricott, has chronic pain and degenerative disc disease.
This is just a sample.
This is just puberty blockers and not even testosterone.